ask="3.20"
ask_size="300"
average_daily_volume="345037"
bid="2.15"
bid_size="1000"
book_value="0.44"
change="+0.06"
change_from_200_day_moving_average="0.17"
change_from_50_day_moving_average="0.18"
change_from_52_week_high="-0.97"
change_From_52_week_low="1.25"
change_in_percent="+2.99%"
close="2.07"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.10"
ebitda="-24.72M"
eps_estimate_current_year="-1.13"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.99"
ex_dividend_date="N/A"
float_shares="21469000"
high="2.15"
high_52_weeks="3.04"
last_trade_date="2/3/2017"
last_trade_price="2.07"
last_trade_size="391"
last_trade_time="4:00pm"
low="1.99"
low_52_weeks="0.82"
market_capitalization="48.54M"
moving_average_200_day="1.90"
moving_average_50_day="1.89"
name="CymaBay Therapeutics Inc."
notes="N/A"
one_year_target_price="7.63"
open="2.01"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+8.70%"
percent_change_from_50_day_moving_average="+9.67%"
percent_change_from_52_week_high="-31.91%"
percent_change_from_52_week_low="+152.44%"
previous_close="2.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.61"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="23447000"
short_ratio="0.86"
stock_exchange="NCM"
symbol="CBAY"
volume="425458"
weeks_range_52="0.82 - 3.04"
